Search research articles
Contact Us
Filters
Showing results (681-690 of 910) with videos related to
Page
of 91
Sort By:
ESC Heart Failure
|
August 9, 2018
Design of the GutHeart-targeting gut microbiota to treat heart failure-trial: a Phase II, randomized clinical trial
Cristiane C K Mayerhofer, Ayodeji O Awoyemi, Samuel D Moscavitch, et al.
Circulation Research
|
November 22, 2008
Inflammatory interaction between LIGHT and proteinase-activated receptor-2 in endothelial cells: potential role in atherogenesis
Wiggo J Sandberg, Bente Halvorsen, Arne Yndestad, et al.
Open Heart
|
December 5, 2019
Selective and marked decrease of complement receptor C5aR2 in human thoracic aortic aneurysms: a dysregulation with potential inflammatory effects
Margrethe Flesvig Holt, Bjørn E Seim, Jonas Øgaard, et al.
Biochemical and Biophysical Research Communications
|
October 2, 2020
N6-methyladenosine in RNA of atherosclerotic plaques: An epitranscriptomic signature of human carotid atherosclerosis
Ana Quiles-Jiménez, Ida Gregersen, Mirta Mittelstedt Leal de Sousa, et al.
Plos One
|
August 24, 2018
Differential expression of vitamin D associated genes in the aorta of coronary artery disease patients with and without rheumatoid arthritis
Ingvild Oma, Ole Kristoffer Olstad, Jacqueline Kirsti Andersen, et al.
Scientific Reports
|
March 19, 2022
Serum markers of cardiac complications in a systemic sclerosis cohort
Anders H Tennøe, Klaus Murbræch, Henriette Didriksen, et al.
European Journal of Endocrinology
|
December 16, 2011
Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies
John Willy Haukeland, Tuva B Dahl, Arne Yndestad, et al.
European Heart Journal
|
May 11, 2016
Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial
Ola Kleveland, Gabor Kunszt, Marte Bratlie, et al.
Psychoneuroendocrinology
|
March 1, 2016
Inflammatory evidence for the psychosis continuum model
Ragni H Mørch, Ingrid Dieset, Ann Færden, et al.
European Heart Journal. Acute Cardiovascular Care
|
April 25, 2019
Pentraxin-3 vs C-reactive protein and other prognostic biomarkers in acute coronary syndrome: A substudy of the Platelet Inhibition and Patients Outcomes (PLATO) trial
Frederic Kontny, Thomas Andersen, Thor Ueland, et al.
Page
of 91
Search research articles
Search
Showing results (681-690 of 910) with videos related to
Sort By:
Page
of 91
ESC Heart Failure
|
August 9, 2018
Design of the GutHeart-targeting gut microbiota to treat heart failure-trial: a Phase II, randomized clinical trial
Cristiane C K Mayerhofer, Ayodeji O Awoyemi, Samuel D Moscavitch, et al.
Circulation Research
|
November 22, 2008
Inflammatory interaction between LIGHT and proteinase-activated receptor-2 in endothelial cells: potential role in atherogenesis
Wiggo J Sandberg, Bente Halvorsen, Arne Yndestad, et al.
Open Heart
|
December 5, 2019
Selective and marked decrease of complement receptor C5aR2 in human thoracic aortic aneurysms: a dysregulation with potential inflammatory effects
Margrethe Flesvig Holt, Bjørn E Seim, Jonas Øgaard, et al.
Biochemical and Biophysical Research Communications
|
October 2, 2020
N6-methyladenosine in RNA of atherosclerotic plaques: An epitranscriptomic signature of human carotid atherosclerosis
Ana Quiles-Jiménez, Ida Gregersen, Mirta Mittelstedt Leal de Sousa, et al.
Plos One
|
August 24, 2018
Differential expression of vitamin D associated genes in the aorta of coronary artery disease patients with and without rheumatoid arthritis
Ingvild Oma, Ole Kristoffer Olstad, Jacqueline Kirsti Andersen, et al.
Scientific Reports
|
March 19, 2022
Serum markers of cardiac complications in a systemic sclerosis cohort
Anders H Tennøe, Klaus Murbræch, Henriette Didriksen, et al.
European Journal of Endocrinology
|
December 16, 2011
Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies
John Willy Haukeland, Tuva B Dahl, Arne Yndestad, et al.
European Heart Journal
|
May 11, 2016
Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial
Ola Kleveland, Gabor Kunszt, Marte Bratlie, et al.
Psychoneuroendocrinology
|
March 1, 2016
Inflammatory evidence for the psychosis continuum model
Ragni H Mørch, Ingrid Dieset, Ann Færden, et al.
European Heart Journal. Acute Cardiovascular Care
|
April 25, 2019
Pentraxin-3 vs C-reactive protein and other prognostic biomarkers in acute coronary syndrome: A substudy of the Platelet Inhibition and Patients Outcomes (PLATO) trial
Frederic Kontny, Thomas Andersen, Thor Ueland, et al.
Page
of 91